Health Canada: Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) beyond 20 weeks of pregnancy and risk of kidney damage in unborn babies, leading to low amniotic fluid


Health Canada is investigating the use of non-steroidal anti-inflammatory drugs (NSAIDs) at 20 weeks or later in pregnancy and the rare, but serious, risk of kidney problems in an unborn baby, in response to a Drug Safety Communication recently released by the U.S. Food and Drug Administration (FDA) on this issue.

NSAIDs are commonly used to relieve pain and reduce fevers. They include medicines such as acetylsalicylic acid (aspirin), ibuprofen, naproxen, diclofenac and celecoxib.

Read the statement from Health Canada HERE